Dr Schrag on Neoadjuvant Chemotherapy and Selective Chemoradiation in Locally Advanced Rectal Cancer

Deb Schrag, MD, MPH, discusses findings from the phase 2/3 PROSPECT trial in patients with rectal cancer.

Related Keywords

Georgej Bosl ,Deb Schrag ,Memorial Sloan Kettering Cancer Center ,Department Of Medicine ,D ,Bph ,Prospect Trial ,Nct01515787 ,Patients With Rectal Cancer ,